RadNet (NASDAQ:RDNT) (NASDAQ: RDNT) is an outpatient diagnostic imaging company that operates imaging centers and provides related healthcare services. Its facilities offer diagnostic radiology and imaging procedures used to help detect, diagnose, and monitor medical conditions.
The company’s services generally include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound, X-ray, and other imaging procedures. RadNet also provides image-guided and interventional radiology services in selected markets, along with digital imaging, radiology, and information-technology solutions.
Founded in 1981, RadNet serves patients, physicians, hospitals, and other healthcare organizations through a network of outpatient imaging centers primarily located in the United States, including markets in California, New York, New Jersey, Maryland, and Delaware. The company has also expanded its digital health capabilities through its DeepHealth platform, which uses technology and artificial intelligence to support imaging workflows and clinical decision-making.
RadNet is led by Chief Executive Officer Howard G. Berger, who has served in senior leadership roles with the company for many years. Its business combines direct patient imaging services with technology and clinical-support solutions intended to improve access to outpatient radiology care.
